DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20170917

Pap smear screening: a retrospective study

Anjali Soni

Abstract


Background: Cervical cancer is the seventh cancer in overall frequency, but the second most common cancer among women worldwide. The objective was to study the population undergoing pap-smear screening.

Methods: It is retrospective study conducted in general hospital, GMERS Medical College Gotri, Gujarat, India. Total 1003 patients who attended OPD have undergone routine pap smear screening over period of 6 months from January 2016 to June 2016. Cytotological examination was done and test results were classified according to Bethesda system.

Results: Abnormal tests were found in 36 patients.

Conclusions: Pap smear a routine screening test offered to every woman who comes to our OPD irrespective of her complaints. Every woman at least once in her lifetime should go for pap-smear examination. It is effective screening test for cervical carcinoma. It is cost effective test with high specificity and very easy to perform so it becomes the method of choice for cervical carcinoma screening. With proper follow up patients with abnormal tests are screened and appropriate treatment is being offered to patients.

Keywords


Cervical cancer, Pap smear, Screening program

Full Text:

PDF

References


Denny L. Cervical cancer: prevention and treatment. Discov Med. 2012;14:125-31.

Shanta V, Krishnamurthi S, Gajalakshmi CK, Swaminathan R, Ravichandran K. Epidemiology of cancer of cervix: Global and national perspective. J Indian Med Assoc. 2000;98:49-52.

Biennial report (2000-2001) Lyon: IARC; 2001. WHO/IARC.

Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.

Garner EI. Cervical cancer: disparities in screening, treatment, and survival. Cancer Epidemiol Biomarkers Prev. 2003;12(3):242s-7s.

Planning and implementing cervical cancer prevention and control programs: a manual for managers. Seattle: AACP; Alliance for Cervical Cancer Prevention; 2004.

Nandakumar A, Ramnath T, Chaturvedi M. The magnitude of cancer cervix in India. Indian J Med Res. 2009;130(3):219-21.

World- both sexes estimated incidence by age. [Accessed October 30, 2014]. Available from: http://www.globocan.iarc.fr/old/age_specific_table_r.asp?

Human Papilloma Virus ICMR: High power Committee to Evaluate Performance of ICMR, 2012-2013. Disease Specific Documents for XII plan. New Delhi, India: ICMR; 2014.

Denny L, Sankaranarayanan R. Secondary prevention of cervical cancer. Int J Gynaecol Obstet. 2006;94(1):S65-70.

Hakama M, Rasanen-Virtanen U. Effectiveness of mass screening program on the risk of cervical cancer. Am J Epidemiol. 1989;(17):173-204.

Alliance for cervical cancer prevention (ACCP) planning and implementing cervical cancer prevention and control programs: A Manual for Managers. Seattle, WA, USA: ACCP; 2004.

Seema P, Paul B, Boffetta P. Meta analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003;105:687-91.